<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:91065749</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="type-II_estrogen_binding_site" sem="G#protein_family_or_group"><w c="JJ">Type-II</w> <w c="NN">estrogen</w> <w c="NN">binding</w> <w c="NNS">sites</w></cons> <w c="IN">in</w> <w c="DT">a</w> <cons lex="lymphoblastoid_cell_line" sem="G#cell_line"><w c="JJ">lymphoblastoid</w> <w c="NN">cell</w> <w c="NN">line</w></cons> <w c="CC">and</w> <w c="JJ">growth-inhibitory</w> <w c="NN">effect</w> <w c="IN">of</w> <cons lex="estrogen" sem="G#lipid"><w c="NN">estrogen</w></cons><w c=",">,</w> <cons lex="anti-estrogen" sem="G#other_organic_compound"><w c="NN">anti-estrogen</w></cons> <w c="CC">and</w> <cons lex="bioflavonoid" sem="G#other_organic_compound"><w c="NNS">bioflavonoids</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><cons lex="yype-II_estrogen-binding_site" sem="G#protein_family_or_group"><w c="JJ">Type-II</w> <cons lex="estrogen" sem="G#lipid"><w c="*">estrogen</w></cons><w c="JJ">-binding</w> <w c="NNS">sites</w></cons> <w c="(">(</w><cons lex="type-II_EBS" sem="G#protein_family_or_group"><w c="JJ">type-II</w> <w c="NNS">EBS</w></cons><w c=")">)</w> <w c="VBP">have</w> <w c="VBN">been</w> <w c="VBN">demonstrated</w> <w c="IN">in</w> <w c="DT">the</w> <cons lex="human_lymphoblastoid_cell_line" sem="G#cell_line"><w c="JJ">human</w> <cons lex="lymphoblastoid_cell_line" sem="G#cell_line"><w c="JJ">lymphoblastoid</w> <w c="NN">cell</w> <w c="NN">line</w></cons></cons> <cons lex="IM-9" sem="G#cell_line"><w c="NN">IM-9</w></cons> <w c="VBG">using</w> <w c="DT">a</w> <cons lex="whole-cell_assay" sem="G#other_name"><w c="JJ">whole-cell</w> <w c="NN">assay</w></cons> <w c="IN">with</w> <cons lex="(6,7-3H)_estradiol" sem="G#lipid"><w c="(">(</w><w c="NN">6,7-3H</w><w c=")">)</w> <w c="NN">estradiol</w></cons> <w c="(">(</w><cons lex="3H-E2" sem="G#lipid"><w c="NN">3H-E2</w></cons><w c=")">)</w> <w c="IN">as</w> <w c="NN">tracer</w><w c=".">.</w></sentence>
<sentence><w c="NN">Competition</w> <w c="NN">analysis</w> <w c="VBD">showed</w> <w c="IN">that</w> <w c="DT">the</w> <cons lex="anti-estrogen" sem="G#other_organic_compound"><w c="JJ">anti-estrogen</w></cons> <cons lex="tamoxifen" sem="G#other_organic_compound"><w c="NN">tamoxifen</w></cons> <w c="CC">and</w> <w c="DT">the</w> <cons lex="flavonoid" sem="G#other_organic_compound"><w c="NNS">flavonoids</w></cons> <cons lex="quercetin" sem="G#other_organic_compound"><w c="NN">quercetin</w></cons> <w c="CC">and</w> <cons lex="rutin" sem="G#other_organic_compound"><w c="NN">rutin</w></cons> <w c="VBD">competed</w> <w c="IN">for</w> <cons lex="(3H)-E2_binding" sem="G#other_name"><w c="NN">(3H)-E2</w> <w c="NN">binding</w></cons> <w c="TO">to</w> <cons lex="type-II_EBS" sem="G#protein_family_or_group"><w c="JJ">type-II</w> <w c="NNS">EBS</w></cons><w c=".">.</w></sentence>
<sentence><w c="NN">Growth</w> <w c="NNS">experiments</w> <w c="VBD">demonstrated</w> <w c="IN">that</w> <cons lex="diethylstilbestrol" sem="G#other_organic_compound"><w c="NN">diethylstilbestrol</w></cons> <w c="(">(</w><cons lex="DES" sem="G#other_organic_compound"><w c="NN">DES</w></cons><w c=")">)</w> <cons lex="tamoxifen" sem="G#other_organic_compound"><w c="NN">tamoxifen</w></cons> <w c="(">(</w><cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons><w c=")">)</w><w c=",">,</w> <cons lex="quercetin" sem="G#other_organic_compound"><w c="NN">quercetin</w></cons> <w c="CC">and</w> <cons lex="rutin" sem="G#other_organic_compound"><w c="NN">rutin</w></cons> <w c="VBD">exerted</w> <w c="DT">a</w> <w c="JJ">reversible</w> <w c="JJ">dose-dependent</w> <w c="NN">inhibition</w> <w c="IN">of</w> <cons lex="cell_proliferation" sem="G#other_name"><w c="NN">cell</w> <w c="NN">proliferation</w></cons> <w c="IN">in</w> <w c="DT">the</w> <w c="NN">range</w> <w c="IN">of</w> <w c="NNS">concentrations</w> <w c="IN">between</w> <w c="CD">10</w> <w c="NN">nM</w> <w c="CC">and</w> <w c="CD">10</w> <w c="NN">microM</w><w c=".">.</w></sentence>
<sentence><w c="DT">The</w> <cons lex="relative_binding_affinity" sem="G#other_name"><w c="JJ">relative</w> <w c="NN">binding</w> <w c="NN">affinity</w></cons> <w c="IN">of</w> <cons lex="quercetin" sem="G#other_organic_compound"><w c="NN">quercetin</w></cons><w c=",">,</w> <cons lex="rutin" sem="G#other_organic_compound"><w c="NN">rutin</w></cons><w c=",">,</w> <cons lex="DES" sem="G#other_organic_compound"><w c="NN">DES</w></cons> <w c="CC">and</w> <cons lex="TAM" sem="G#other_organic_compound"><w c="NNP">TAM</w></cons> <w c="IN">for</w> <cons lex="type-II_EBS" sem="G#protein_family_or_group"><w c="JJ">type-II</w> <w c="NNS">EBS</w></cons> <w c="VBD">correlated</w> <w c="RB">well</w> <w c="IN">with</w> <w c="PRP$">their</w> <w c="NN">potency</w> <w c="IN">as</w> <cons lex="cell_growth_inhibitor" sem="G#other_name"><w c="NN">cell</w> <w c="NN">growth</w> <w c="NNS">inhibitors</w></cons><w c=".">.</w></sentence>
<sentence><w c="RB">Moreover</w><w c=",">,</w> <w c="NN">hesperidin</w><w c=",">,</w> <w c="DT">a</w> <w c="NN">flavonoid</w> <w c="WDT">which</w> <w c="VBZ">does</w> <w c="RB">not</w> <w c="VB">bind</w> <w c="TO">to</w> <cons lex="type-II_EBS" sem="G#protein_family_or_group"><w c="JJ">type-II</w> <w c="NNS">EBS</w></cons><w c=",">,</w> <w c="VBD">was</w> <w c="JJ">ineffective</w> <w c="IN">in</w> <w c="VBG">inhibiting</w> <cons lex="cell_growth" sem="G#other_name"><w c="NN">cell</w> <w c="NN">growth</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="cell-cycle_analysis" sem="G#other_name"><w c="JJ">Cell-cycle</w> <w c="NN">analysis</w></cons> <w c="VBD">showed</w> <w c="IN">that</w> <w c="DT">the</w> <cons lex="growth-inhibitory_effect" sem="G#other_name"><w c="JJ">growth-inhibitory</w> <w c="NN">effect</w></cons> <w c="IN">of</w> <cons lex="DES" sem="G#other_organic_compound"><w c="NN">DES</w></cons><w c=",">,</w> <cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons> <w c="CC">or</w> <cons lex="quercetin" sem="G#other_organic_compound"><w c="NN">quercetin</w></cons> <w c="VBD">was</w> <w c="JJ">due</w> <w c="TO">to</w> <w c="DT">a</w> <w c="NN">blocking</w> <w c="NN">effect</w> <w c="IN">in</w> <w c="DT">the</w> <w c="JJ">G0-G1</w> <w c="NNS">phases</w><w c=".">.</w></sentence>
<sentence><w c="PRP$">Our</w> <w c="NNS">results</w> <w c="VBP">suggest</w> <w c="IN">that</w> <w c="JJ">high</w> <cons lex="estrogen" sem="G#lipid"><w c="NN">estrogen</w></cons> <w c="CC">and</w> <cons lex="anti-estrogen_concentration" sem="G#other_name"><cons lex="anti-estrogen" sem="G#other_organic_compound"><w c="JJ">anti-estrogen</w></cons> <w c="NNS">concentrations</w></cons> <w c="CC">and</w> <cons lex="flavonoid" sem="G#other_organic_compound"><w c="NNS">flavonoids</w></cons> <w c="MD">may</w> <w c="VB">regulate</w> <cons lex="IM-9" sem="G#cell_line"><w c="NN">IM-9</w></cons> <cons lex="cell_growth" sem="G#other_name"><w c="NN">cell</w> <w c="NN">growth</w></cons> <w c="IN">through</w> <w c="DT">a</w> <w c="JJ">common</w> <w c="NN">mechanism</w> <w c="VBG">involving</w> <w c="DT">a</w> <w c="NN">binding</w> <w c="NN">interaction</w> <w c="IN">with</w> <cons lex="type-II_EBS" sem="G#protein_family_or_group"><w c="JJ">type-II</w> <w c="NNS">EBS</w></cons><w c=".">.</w></sentence>
</abstract>
</article>
